Mark Cuban Cost Plus Drug Company partners with pharma company, COPD Foundation

The collaborators will improve access to Tiotropium Bromide Inhalation Powder in the U.S. for patients with chronic obstructive pulmonary disease (COPD).

from MobiHealthNews https://ift.tt/83COwFL
https://ift.tt/QdrfYmx